Buckley Mortimer J 4

What Happened

• Mortimer J. Buckley, a member of Pfizer's Board of Directors, was granted 1,386.834 derivative units (phantom shares) on March 27, 2026. The filing values the award at $27.04 per unit, for a total grant value of $37,500. This is a director compensation grant (award/acquisition), not an open-market purchase or sale.

Key Details

• Transaction date and price: March 27, 2026; 1,386.834 units at $27.04 each; total $37,500.
• Transaction type: A (award/grant of a derivative security — phantom share units).
• Shares/units owned after transaction: Not specified in this Form 4 filing.
• Filing date and timeliness: Form 4 filed March 30, 2026 — within the SEC’s two-business-day reporting window (timely).
• Footnotes from the filing:
  • F1: Each unit represents one phantom share of common stock.
  • F2: These units are deferred director compensation (including dividend equivalents) that will be settled in cash or common stock at the director’s election following retirement from the Board.

Context

• These are derivative phantom-share units used for deferred director pay, not immediately tradable common stock. Such grants are routine director compensation and do not necessarily indicate the director bought or sold company stock on the open market.